Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025

Core Insights - Anika Therapeutics, Inc. will release its third quarter 2025 financial results on November 5, 2025, before market opening, followed by a conference call at 8:30 a.m. ET to discuss the results and business highlights [1]. Company Overview - Anika Therapeutics, Inc. is a global joint preservation company focused on early intervention orthopedic care, specializing in hyaluronic acid and implant solutions [3]. - The company aims to provide minimally invasive products that enhance active living, targeting high opportunity areas in orthopedics such as Osteoarthritis Pain Management and Regenerative Solutions [3]. - Anika's operations are headquartered outside of Boston, Massachusetts, and its products are delivered efficiently in key care sites, including ambulatory surgery centers [3].